Iran, Islamic Republic of vs Rwanda: Immunization, Hib3
Iran, Islamic Republic of
98.0%
in 2024
Rwanda
98.0%
in 2024
Iran, Islamic Republic of rank
20th
Rwanda rank
20th
Immunization, Hib3 over time
- Iran, Islamic Republic of
- Rwanda
How they compare
Iran, Islamic Republic of currently reports 98.0% against 98.0% in Rwanda, a difference of 0.0%.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Rwanda ahead.
Iran, Islamic Republic of ranks 20th and Rwanda ranks 20th of 191 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8% | 97.8% | 1.0% | Iran, Islamic Republic of |
| 2020s | 98.6% | 93.8% | 4.8% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Iran, Islamic Republic of or Rwanda?
- Iran, Islamic Republic of, at 98.0% against 98.0% in Rwanda as of 2024.
- What is the difference in immunization, hib3 between Iran, Islamic Republic of and Rwanda?
- 0.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Rwanda?
- 10 years are reported by both, from 2015 to 2024.
- How do Iran, Islamic Republic of and Rwanda rank globally for immunization, hib3?
- Iran, Islamic Republic of ranks 20th and Rwanda ranks 20th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.